Theriva Biologics, Inc. (TOVX) is a publicly traded Healthcare sector company. As of October 16, 2026, TOVX trades at $0.21 with a market cap of $9.63M and a P/E ratio of -0.11. TOVX moved +1.29% today. Year to date, TOVX is -18.64%; over the trailing twelve months it is -52.00%. Its 52-week range spans $0.16 to $1.60. Analyst consensus is buy with an average price target of $1.00. Rallies surfaces TOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for TOVX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.21 |
| Market Cap | $9.63M |
| P/E Ratio | -0.11 |
| EPS | $-2.08 |
| Dividend Yield | 0.05% |
| 52-Week High | $1.60 |
| 52-Week Low | $0.16 |
| Volume | 32.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.74M |
| Gross Margin | 0.00% |
1 analysts cover TOVX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $1.00.